Related Experiment Video
Updated: May 29, 2026

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics
Published on: July 16, 2018
Chemical efflux imaging using an annular nanosensor array for in situ bladder cancer detection
Wonjun Yim1, Hohyung Kang1, Byung Ha Kang1
1Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
Abstract:
Detection of analytes in extracted biofluids, such as urine for bladder cancer biomarkers, is challenging owing to sample dilution and instability outside the human body. Here we demonstrate an annular nanosensor array grafted onto a standard biomedical catheter, which enables three-dimensional chemical efflux imaging from within a tissue compartment or luminal space. This platform integrates near-infrared fluorescent single-walled carbon nanotubes with the catheter, leveraging a ball-lens scanning optical device for chemical signal mapping. We develop nanosensors based on a phospholipid copolymer that selectively detect nuclear matrix protein (NMP-22), a biomarker for bladder cancer. The results show differential sensor responses between apoptosis in six bladder cancer cell lines and healthy fibroblast cells. Nanosensor-functionalized catheters track gemcitabine-stimulated cell death and monitor protein efflux in vitro. We demonstrate spatial imaging of incident chemical flux using this platform, achieving localization of biomarker sources in complex tissues and organs with 182-fold signal enhancement compared with extracted biofluid sampling. As an application, the catheter equipped with a rotating ball lens chemically images porcine bladders, detecting biomarker efflux up to 2 cm away, highlighting its potential as a point-of-care diagnostic tool.

